Transcriptomics

Dataset Information

0

A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma

ABSTRACT: High-througput transcriptome analysis by RNA-seq of multiple myeloma tumor samples (CD138+ cells) in subjects treated with pomalidomide, daily low dose oral cyclophosphamide and dexamethasone in the context of a phase II clinical trial. Samples were collected at baseline as a correlative study to determine whether gene expression profiles could distinguish patients with (un)favorable response to treatment.

ORGANISM(S): Homo sapiens

PROVIDER: GSE138717 | GEO | 2019/10/11

REPOSITORIES: GEO

Json Xml

Similar Datasets

Genomics A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma
| PRJNA576896 | ENA
Unknown Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma.
| S-EPMC4643003 | biostudies-literature
Unknown Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)-a trial by the Asian Myeloma Network.
| S-EPMC6783445 | biostudies-literature
Transcriptomics Expression analysis after co-treatment of GSK126 and pomalidomide
2020-09-23 | GSE147320 | GEO
Unknown Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment.
| S-EPMC7685974 | biostudies-literature
Unknown Immunomodulation by durvalumab and pomalidomide in patients with relapsed/refractory multiple myeloma.
| S-EPMC8361181 | biostudies-literature
Unknown Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma.
| S-EPMC5570682 | biostudies-literature
Unknown Pomalidomide, bortezomib, and dexamethasone for patients with relapsed lenalidomide-refractory multiple myeloma.
| S-EPMC5606008 | biostudies-literature
Unknown Pomalidomide alone or in combination with dexamethasone in Japanese patients with refractory or relapsed and refractory multiple myeloma.
| S-EPMC4714698 | biostudies-other
Unknown Effect of pomalidomide on relapsed/refractory multiple myeloma: a systematic review and meta-analysis.
| S-EPMC5556643 | biostudies-other